This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

8 Stocks Rising on Monster Volume

Stocks in this article: HTWR JAKK AMLN BEAV SNDK SCSS SSYS GRPN

Amylin Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Amylin Pharmaceuticals (AMLN) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. This stock is trading up 11.5% at $25.58 in recent trading.

Today's Volume: 9.7 million

Average Volume: 5.15 million



Volume % Change: 207%

>>5 Big Stocks to Trade or Gains

Shares of AMLN are surging higher today after a report hit the wires that the company is reaching out to potential buyers about a possible sale. Reuters said that AMLN is looking for buyers and has hired Credit Suisse and Goldman Sachs as financial advisers.

From a technical perspective, AMLN is gapping up sharply today on monster volume. This move is quickly pushing the stock within range of triggering a big breakout trade. That trade will hit once AMLN can manage to move or close above some near-term overhead resistance at $25.84 with high-volume.

Traders should now look for long-biased traders in AMLN as long as this stock is trending above $25.84 with strong upside volume flows. I would consider any upside volume day that registers near or above 5.15 million shares as strong. Look for AMLN to close near or above its daily high today of $25.96 as a sign that the upside momentum will continue in the short-term.

A possible target is $30 if we get a strong close, and we continue to see AMLN trending above $25.84 with strong upside volume flows.

4 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.83 -27.26 -1.33%
NASDAQ 4,684.0540 -87.7090 -1.84%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs